NL-OMON33662
Recruiting
N/A
Improvement of ischemia and myocardial blood flow in patients with ischemic cardiomyopathy after treatment with Electric Shock Wave Therapy using CMR - Electric Shock Wave Therapy
Overview
- Phase
- N/A
- Intervention
- Not specified
- Conditions
- Heart failure
- Sponsor
- Vrije Universiteit Medisch Centrum
- Enrollment
- 8
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •\* Patient is male or female 18 years or older.
- •\* Patient is diagnosed with ischemic cardiomyopathy. I.e. a significantly impaired left ventriculair dysfunction (left ventricular ejection fraction \* 35 to 40 percent) that results from coronary artery disease based on a coronary angiogram.
- •\* Patient has documented myocardial segments with reversible ischemia and or hibernation.
- •\* Patient is classified as NYHA class II\-IV.
- •\* Patient should be on a stable dosage of medication used to treat angina for at least 6 weeks prior to enrollment.
- •\* Patients where angioplasty and bypass are not indicated because of anatomical or procedural reasons or frequent reocclusion / restenosis following traditional revascularization.
- •\* Patient has refused to undergo another angioplasty or CABG.
Exclusion Criteria
- •\* Patient has chronic lung disease including emphysema and pulmonary fibrosis.
- •\* Patient has active endocarditis, myocarditis or pericarditis.
- •\* Patient is simultaneously participating in another device or drug study, or has participated in any clinical trial involving an experimental device or drug, including other drugs or devices enhancing cardiac neovascularization.
- •\* Patients who are unwilling or unable to cooperate with study procedure.
- •\* Patients with renal dysfunction with eGFR\<30 ml/min
- •\* Patients who are unwilling to quit smoking during the study procedure (including screening phase)
- •\* Patients who had MI less than 3 months prior to treatment
- •\* Patients who are diagnosed with a 3rd and 4th degree heart valve disease.
- •\* Patient with intraventricular thrombus
- •\* Patient is pregnant
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
N/A
Improvement of blood pressure and blood flow by intake of test articleJPRN-UMIN000033336Japan clinical trial association54
Completed
N/A
A study for improving effects on the blood flow and the skin by carbonate cosmeticsHealthy adultsJPRN-UMIN000025658Kao Corporation40
Completed
N/A
Myocardial perfusion and microvascular dysfunction in stable coronary artery disease during hyperoxaemiaISRCTN67819491niversity of Leeds (UK)90
Not Yet Recruiting
N/A
Consideration of cardiac function improvement effect of Omega-3 fatty acids(EPA +DHA)Chronic heart failure patient with dyslipidemiaJPRN-UMIN000017867Kyorin University School of Medicine, Second department of Internal Medicine30
Recruiting
Phase 4
Clinical effect of promoting blood circulation and removing stasis on improving cognitive function of patients with hypertension arteriosclerosis and cerebral small vessel diseaseSmall cerebral vascular diseaseITMCTR2200006595The First Clinical Medical College of Beijing University of Chinese Medicine